Atrial Flow Regulator for Postcapillary Pulmonary Hypertension : First-in-Human Transcatheter AFR Device Implantations in RCM

© 2022 The Authors..

Restrictive cardiomyopathy (RCM) has a poor prognosis and limited treatment options apart from heart transplantation (HTx). We report on the first-in-human interventional atrial flow regulator (AFR) implantations in 3 children with RCM, leading to marked clinical and hemodynamic improvement. We propose the AFR as bridge to HTx or destination therapy in RCM. (Level of Difficulty: Advanced.).

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:4

Enthalten in:

JACC. Case reports - 4(2022), 14 vom: 20. Juli, Seite 878-884

Sprache:

Englisch

Beteiligte Personen:

Hansmann, Georg [VerfasserIn]
Sabiniewicz, Anna [VerfasserIn]
Sabiniewicz, Robert [VerfasserIn]

Links:

Volltext

Themen:

AFR, atrial flow regulator
Atrial flow regulator device
Case Reports
HF, heart failure
HFpEF, heart failure with preserved ejection fraction
HTx, heart transplantation
Heart failure
LA, left atrium
LAP, left atrial pressure
LV, left ventricle
LVEDP, left ventricular end-diastolic pressure
Left atrial hypertension
MR, magnetic resonance
NYHA, New York Heart Association
PAWP, pulmonary artery wedge pressure
PH, pulmonary hypertension
PVR, pulmonary vascular resistance
Pulmonary hypertension
Pulmonary vascular disease
RCM, restrictive cardiomyopathy
Restrictive cardiomyopathy
Transcatheter intervention

Anmerkungen:

Date Revised 02.08.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.jaccas.2022.05.010

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM344320189